Evidence map›Paper›PMID 35602210›Full record

ArticleCommunications medicine2021

Dual-energy three-compartment breast imaging for compositional biomarkers to improve detection of malignant lesions.

Lambert T Leong, Serghei Malkov, Karen Drukker, Bethany L Niell, Peter Sadowski, Thomas Wolfgruber, Heather I Greenwood, Bonnie N Joe, Karla Kerlikowske, Maryellen L Giger and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lambert T LeongDepartment of Epidemiology and Population Sciences, University of Hawaii Cancer Center, Honolulu, HI USA.ORCID 0000-0002-2927-8458
Serghei MalkovDepartments Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA USA.
Karen DrukkerDepartment of Radiology, University of Chicago, Chicago, IL USA.
Bethany L NiellDepartment of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL USA.
Peter SadowskiDepartment of Information and Computer Science, University of Hawaii at Manoa, Honolulu, HI USA.ORCID 0000-0002-7354-5461
Thomas WolfgruberDepartment of Epidemiology and Population Sciences, University of Hawaii Cancer Center, Honolulu, HI USA.ORCID 0000-0001-8770-1800
Heather I GreenwoodDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA USA.
Bonnie N JoeDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA USA.
Karla KerlikowskeDepartments Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA USA.
Maryellen L GigerDepartment of Radiology, University of Chicago, Chicago, IL USA.ORCID 0000-0001-5482-9728
John A ShepherdDepartment of Epidemiology and Population Sciences, University of Hawaii Cancer Center, Honolulu, HI USA.ORCID 0000-0003-2280-2541
University of California, San Francisco · USUniversity of Hawaiʻi at Mānoa · USUniversity of Chicago · USMoffitt Cancer Center · US

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer DiagnosisR01CA166945 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GIGER, MARYELLEN L., SHEPHERD, JOHN ALAN · 2013 to 2017
$3.3M
NCI NIH HHS P01 CA154292NCI NIH HHS R01 CA166945
6 · The paper itself

Abstract

Background: While breast imaging such as full-field digital mammography and digital breast tomosynthesis have helped to reduced breast cancer mortality, issues with low specificity exist resulting in unnecessary biopsies. The fundamental information used in diagnostic decisions are primarily based in lesion morphology. We explore a dual-energy compositional breast imaging technique known as three-compartment breast (3CB) to show how the addition of compositional information improves malignancy detection. Methods: Women who presented with Breast Imaging-Reporting and Data System (BI-RADS) diagnostic categories 4 or 5 and who were scheduled for breast biopsies were consecutively recruited for both standard mammography and 3CB imaging. Computer-aided detection (CAD) software was used to assign a morphology-based prediction of malignancy for all biopsied lesions. Compositional signatures for all lesions were calculated using 3CB imaging and a neural network evaluated CAD predictions with composition to predict a new probability of malignancy. CAD and neural network predictions were compared to the biopsy pathology. Results: The addition of 3CB compositional information to CAD improves malignancy predictions resulting in an area under the receiver operating characteristic curve (AUC) of 0.81 (confidence interval (CI) of 0.74-0.88) on a held-out test set, while CAD software alone achieves an AUC of 0.69 (CI 0.60-0.78). We also identify that invasive breast cancers have a unique compositional signature characterized by reduced lipid content and increased water and protein content when compared to surrounding tissues. Conclusion: Clinically, 3CB may potentially provide increased accuracy in predicting malignancy and a feasible avenue to explore compositional breast imaging biomarkers.

Indexed as

Breast cancerCancer imaging

Identifiers

PMID35602210
PMCPMC9053198
OpenAlexW3149326820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.